[Form 4] Heartflow, Inc. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Heartflow, Inc. director Casey M. Tansey reported a grant of stock options. On the reported date, Tansey received options covering 16,075 shares of Common Stock at an exercise price of $32.05 per share. Following this grant, Tansey held 16,075 derivative securities directly.
The option will vest in full on the earlier of the day prior to Heartflow's 2027 annual meeting of shareholders and the first anniversary of the grant date, subject to continued service through that date. The options are scheduled to expire on June 16, 2036 if not exercised.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Tansey Casey M
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 16,075 | $32.05 | $515K |
Holdings After Transaction:
Stock Option — 16,075 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Stock options granted: 16,075 options
Exercise price: $32.05 per share
Options held after grant: 16,075 derivative securities
+2 more
5 metrics
Stock options granted
16,075 options
Grant to director Casey M. Tansey on reported date
Exercise price
$32.05 per share
Exercise price for granted stock options
Options held after grant
16,075 derivative securities
Total derivative securities following the transaction
Expiration date
June 16, 2036
Expiration of stock options if not exercised
Underlying shares
16,075 shares of Common Stock
Shares underlying the stock options
Key Terms
Stock Option, Common Stock, grant/award acquisition, annual meeting of shareholders
4 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
grant/award acquisition financial
"transaction_action: "grant/award acquisition""
FAQ
What did Heartflow (HTFL) director Casey M. Tansey report on this Form 4?
Director Casey M. Tansey reported receiving a grant of stock options for 16,075 shares of Heartflow Common Stock. These options are compensation-related, not an open-market purchase, and give the right to buy shares at a fixed exercise price of $32.05 per share.
How many Heartflow (HTFL) stock options were granted to Casey M. Tansey?
The filing shows a grant of 16,075 stock options to director Casey M. Tansey. Each option relates to one share of Heartflow Common Stock, creating potential future ownership if exercised at the stated exercise price, subject to vesting and continued service conditions described in the footnote.
What is the exercise price of Casey M. Tansey’s Heartflow (HTFL) stock options?
The stock options granted to Casey M. Tansey have an exercise price of $32.05 per share. This means Tansey can purchase Heartflow Common Stock at $32.05 if the options vest and are later exercised before their stated expiration date in June 2036.
When do Casey M. Tansey’s Heartflow (HTFL) stock options vest?
The options will vest in full on the earlier of the day before Heartflow’s 2027 annual shareholder meeting and the first anniversary of the grant date. Vesting is conditioned on Tansey’s continued service through that vesting date, as described in the Form 4 footnote.
When do the reported Heartflow (HTFL) stock options expire?
The stock options reported for Casey M. Tansey are scheduled to expire on June 16, 2036. If they are not exercised by that expiration date, they lapse and no longer provide the right to purchase Heartflow Common Stock at the $32.05 exercise price.